Nearly 70% of Akcea's workforce is on the chopping block as Ionis executes major restructuring

About half a year after reabsorbing its lipid-focused spinout Akcea, Ionis is now putting a major reorganization plan in play — one that involves shaving nearly 70% of the subsidiary’s workforce and expanding its distribution deal with Sobi.